48. The method of claim 47, wherein the disease or condition is ischemia.
49. The method of claim 47, wherein the disease or condition is reperfusion injury.
The prior art references cited by the examiner are:
Wang 1077644 CH Oct. 27, 1993
Ning 1113711 CH Dec. 27, 1995
Tanuma 1 3-205402 JP Sept. 6, 1991
Tanuma 2 4-13684 JP Jan. 17, 1992
Wen et al. (Wen), “Ginseng root prevents learning disability and neuronal loss in gerbils
with 5 minute forebrain ischemia,” Acta Neuropathol., Vol. 91, pp. 15-22 (1996).
Kim et al. (Kim), “Effects of Ginseng on Global Myocardial Ischemia and Reperfusion in
the Rat Heart,” J. Pharm Soc. Korea, Vol. 32, No. 1, pp. 70-79 (1988) [BIOSIS Abstract
Only].
Grounds of Rejection
I. Claims 46-49 stand rejected under 35 U.S.C. §112, first paragraph for lack of
enablement.
II. Claims 46-49 stand rejected under 35 U.S.C. §102(b) over Wang, Ning and
Tanuma 1 and 2.
III. Claims 46-49 stand rejected under 35 U.S.C. §103(a) over Wang, Ning,
Tanuma 1 and 2 in further view of Kim and Wen.
We reverse rejections I-III.
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next
Last modified: November 3, 2007